HOME > 홍보/투자정보 > 산업동향
난치병 치료 유전자치료제 미래신약 주목…국내 임상만 67건
ViroMed
2018/08/15
www.newsis.com/view/?id=NISX20180814_0000390402&cID=13001&pID=13000

http://www.newsis.com/view/?id=NISX20180814_0000390402&cID=13001&pID=13000